ICON plc | Clinical Research Organisation (CRO) for Drug Development

Keeping eCOA implementation off a trial’s critical path

A best-practice approach.

How to engage healthcare decision-makers

Understanding healthcare decision-makers preferences.

A guide to safety data migrations

Choosing the best approach to maintain data integrity.

Fortifying vaccines: Preparation and prevention against future infectious disease epidemics

Beyond buzzwords: Diversity, equity and inclusion in rare disease clinical trials

Advancing DE&I in rare disease clinical research.

Featured Solutions

Early Clinical and Bioanalytical Solutions

Innovative early clinical solutions that will advance your drug development strategy.

Seeking parallel consultation from regulators and HTA bodies in Europe

Market Access

Expertise in mission-critical pricing, market access, and reimbursement.�

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional outsourcing

ICON is the world's largest provider of FSP services.

Webinars

Minimising the impact of cross-cultural differences in COA translations

27 June�2023. Register now.

Exploring partnership culture and its impact on outsourcing and operational strategy

Watch the webinar.

Studies with 13C- and 14C-labelled investigational medicinal products in humans

Watch the webinar.

ICON Insights

15 May 2023

The impact of the new EU Clinical Trial Regulation on language translation

On January 31st, 2023, the EU Clinical Trial Regulation and the Clinical Trial Information System went live and changed the European landscape for clinical trials.

15 May 2023

Biotech’s evolving relationship with CROs

In this blog, read more on recent trends and learn why strategic outsourcing is a key opportunity.

05 May 2023

Recent trends in the biotech funding environment

In this blog, discover more�about how the biotech sector is transforming uncertainty into opportunity.

24 April 2023

Improving the experience of healthy volunteers during early phase clinical trials

How ICON’s application of a volunteer-centric approach is improving recruitment and retention rates of healthy participants in early phase studies.

21 April 2023

Pre-emptive vaccine research to improve EID response

This blog explores strategies for strengthening vaccine development so that the medical community is better prepared to respond to future epidemics.

18 April 2023

Use of ddPCR and qPCR assays for PK and safety monitoring in Cell & Gene Therapy clinical trials

Immunotherapy technologies are rapidly advancing, as are the methods of ensuring their safety and reliability. ICON explores the tools used in CGT trials.

13 April 2023

From clinician visits to data analysis: the challenges and solutions in COVID vaccine pharmacovigilance

Learn more about the challenges and solutions in assessing the long-term effects of Covid and Covid vaccines in this blog.

30 March 2023

Mary O’Reilly reflects on International Women’s Day

In this blog, Mary O’Reilly reflects on the International Women’s Day panel and events held at ICON’s global headquarters in Dublin.

23 March 2023

How data science is changing the face of healthcare

In this podcast, Michael Goedde shares his journey in technology and his role in building the digital platform for healthcare systems at ICON.

Solutions

Sectors

Therapeutics

Insights

News & Events

About ICON

Environment, Social & Governance

EU Clinical Trial Regulation: Impact and strategic considerations for sponsors

Evidence Synthesis